EVH Call for Experts to Join its independent External Advisory Committee (iEAC)
The European Vaccines Hub (EVH) is launching a call for internationally recognized experts to join its independent External Advisory Committee (iEAC).
This independent advisory body will support the EVH Steering Committee (SC) by offering advice on the Hub’s orientation and providing objective scientific, technological, and strategic guidance across the project’s activities, aligned with EVH’s mission to strengthen Europe’s pandemic preparedness capacity within its four core pillars.
About the independent External Advisory Committee (iEAC)
An independent External Advisory Committee (iEAC) will be set up to assist the Steering Committee in ensuring the highest scientific, regulatory, and strategic standards throughout the EVH project’s lifetime.
The iEAC will be composed to ensure a balanced representation of key skills and expertise relevant to vaccine and monoclonal antibody research, development, preclinical and clinical studies, regulation, and manufacturing.
The members of the iEAC will be selected by the Steering Committee, following an open call for interest addressed to international experts.
The iEAC will be invited to join ad hoc meetings to assess progress and provide recommendations on scientific, technological, pre-clinical and clinical regulatory, or production-related aspects of the project.
The Steering Committee may decide to follow—or not—the recommendations provided.
Role and Responsibilities of the iEAC
The iEAC acts as an advisory board to the entire EVH and in particular to the Steering Committee. In line with the governance structure and fully compliant with the EVH Grant and Consortium Agreements, the iEAC will undertake the following responsibilities:
- Core Advisory Functions
- Advising the Steering Committee upon request of the Coordination, providing non‑binding advice to support SC decision‑making.
- Providing guidance to the Beneficiaries and the Steering Committee on scientific, technical, regulatory, and project‑related issues.
- Offering advice on compliance with European regulations, as well as with guidelines, laws, and regulatory frameworks applicable in countries where studies are performed.
- Additional Strategic Advisory Functions
The iEAC will be consulted on whether an EVH open call should be launched, with the final decision resting with the EVH Steering Committee. Once decided, the consortium will inform HERA and HaDEA, which may seek input from the Independent Review Panel on an ad‑hoc basis. The calls will be widely disseminated across Europe and evaluated through a transparent process managed by an Evaluation Committee chaired by the Project Coordinator and composed of the Steering Committee and at least three iEAC experts.
Relevant Competencies Required
EVH is recruiting distinguished experts with proven experience in one or more of the following areas:
- Vaccine technology platforms (mRNA, viral vectors, protein subunit, next generation platforms)
- Monoclonal antibody development
- Immunology, correlates of protection, and preclinical models
- Clinical trial design, harmonization, and standardization
- Clinical trial conduct/execution and relevant clinical practice
- Regulatory science, CHIM models, and ethics frameworks
- GMP biomanufacturing, scale up, and process development
- AI, data science, computational modelling, bioinformatics
- Epidemiology, public health preparedness, outbreak response
- BSL 3/BSL 4 pathogens and high containment vaccine development
Commitment and Meeting Structure
The iEAC will meet upon request of the Coordination Team but at least once every twelve (12) months during the Action. Additional ad hoc meetings will be convened as necessary to support EVH needs. Upon a joint request of the Coordinator, the iEAC will be able to call to meetings additional experts covering particular fields of expertise on a case by case basis.
Eligibility Requirements
Applicants should demonstrate:
- Recognized expertise in relevant scientific, regulatory, or industrial domains
- Proven track record in pandemic preparedness, vaccine development, or related fields
- Independence from EVH operations and capacity to provide impartial advice
- Availability to attend regular and ad hoc meetings
Application Process
Applications will be reviewed on a rolling basis and evaluated shortly after closure. Final appointments will be made by the EVH Steering Committee. Applicants will be informed of the outcome end of June 2026.
How to Apply
Interested experts should submit by 29 May 2026 via the EVH iEAC Application Portal:
- CV (max. 4 pages)
- Motivation letter outlining relevant expertise and interest
- Declaration of absence of conflict interests